Latent autoimmune diabetes of adulthood (LADA): An often misdiagnosed type of diabetes mellitus

被引:19
作者
Appel, Susan J. [1 ]
Wadas, Theresa M. [2 ,3 ]
Rosenthal, Richard S. [4 ]
Ovalle, Fernando [4 ]
机构
[1] Univ Alabama Birmingham, Sch Nursing, Acute & Continuing Care Nurse Practitioner Progra, Birmingham, AL USA
[2] Univ Alabama Birmingham, ACNP RNFA, Birmingham, AL USA
[3] Univ Arizona, Tucson, AZ USA
[4] Univ Alabama Birmingham, Sch Med, Div Endocrinol Diabet & Metab, Birmingham, AL USA
来源
JOURNAL OF THE AMERICAN ACADEMY OF NURSE PRACTITIONERS | 2009年 / 21卷 / 03期
关键词
Diabetes mellitus; LADA; autoimmune; type; 1; 5; diabetes; INSULIN-RESISTANCE; PREVENTION;
D O I
10.1111/j.1745-7599.2009.00399.x
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The purpose of this article is to raise awareness about a frequently misdiagnosed form of diabetes, latent autoimmune diabetes of adulthood (LADA), to describe its clinical and epidemiological characteristics, and to compare them to those of the more common and widely known types of diabetes, type 1 diabetes mellitus (DM) and type 2 DM. A review of the pertinent literature describing the features of LADA from 2000-2007 is summarized. LADA is a rather common and often underrecognized form of diabetes whose clinical presentation falls somewhere between that of type 1 DM and type 2 DM. From a pathophysiological perspective, it is more closely related to type 1 DM, and some have even used the term type 1.5 diabetes to refer to it; however, it is most often misdiagnosed and treated as type 2 DM. Nurse practitioners (NPs) should always consider alternate diagnoses when patients with newly or previously identified adult-onset diabetes mellitus do not fit the traditional stereotype of type 2 DM (i.e., overweight with signs of insulin resistance and a significant family history of diabetes). Statistically, strong consideration must be given to the diagnosis of LADA, especially in those who are of normal weight, show little evidence of insulin resistance, and have hardly any family history of diabetes. Knowing the patient's exact diabetes type can give the NP a much greater understanding of the natural history of the patient's disease, the changes that may occur as the patient ages, and how to optimally manage their diabetes to minimize complications. Likewise, when a patient is correctly diagnosed, they can be empowered to manage their diabetes with the appropriate therapies.
引用
收藏
页码:156 / 159
页数:4
相关论文
共 16 条
  • [1] Familial clustering of autoimmune diseases in patients with type 1 diabetes mellitus
    Anaya, Juan-Manuel
    Castiblanco, John
    Tobon, Gabriel J.
    Garcia, Jorge
    Abad, Veronica
    Cuervo, Hector
    Velasquez, Alejandro
    Angel, Ivan D.
    Vega, Patricia
    Arango, Alvaro
    [J]. JOURNAL OF AUTOIMMUNITY, 2006, 26 (03) : 208 - 214
  • [2] Thiazolidinediones for the prevention of diabetes in the non-obese diabetic (NOD) mouse: implications for human type 1 diabetes
    Beales, PE
    Pozzilli, P
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2002, 18 (02) : 114 - 117
  • [3] Insulin resistance in latent autoimmune diabetes of adulthood
    Behme, MT
    Dupré, J
    Harris, SB
    Hramiak, IM
    Mahon, JL
    [J]. IMMUNOLOGY OF DIABETES II: PATHOGENESIS FROM MOUSE TO MAN, 2003, 1005 : 374 - 377
  • [4] Bell David S H, 2004, Am J Ther, V11, P308, DOI 10.1097/01.mjt.0000102372.28723.2b
  • [5] Equivalent insulin resistance in latent autoimmune diabetes in adults (LADA) and type 2 diabetic patients
    Chiu, Harvey K.
    Tsai, Elaine C.
    Juneja, Rattan
    Stoever, James
    Brooks-Worrell, Barbara
    Goel, Amit
    Palmer, Jerry P.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 77 (02) : 237 - 244
  • [6] Falorni A, 2002, ANN NY ACAD SCI, V958, P99
  • [7] A clinical screening tool identifies autoimmune diabetes in adults
    Fourlanos, S
    Perry, C
    Stein, MS
    Stankovich, J
    Harrison, LC
    Colman, PG
    [J]. DIABETES CARE, 2006, 29 (05) : 970 - 975
  • [8] Latent autoimmune diabetes in adults (LADA) should be less latent
    Fourlanos, S
    Dotta, F
    Greenbaum, CJ
    Palmer, JP
    Rolandsson, O
    Colman, PG
    Harrison, LC
    [J]. DIABETOLOGIA, 2005, 48 (11) : 2206 - 2212
  • [9] GRASSO YZ, 2007, ENDOCRINOLOGY PRACTI, V7, P339
  • [10] Litonjua Patrick, 2004, Endocr Pract, V10, P101